Advertisement
News
Subscribe to MDT Magazine News

Radiologists Need to Contribute to Research

May 9, 2011 1:33 pm | by Diagnostic Imaging | Comments

Only a few radiologists understand how to make a policy case for the value of diagnostic procedures. More need to contribute to research and prove that continued coverage is worthwhile.

TOPICS:

Knowing When Work Has Taken Over Your Life

May 9, 2011 1:33 pm | by Diagnostic Imaging | Comments

I recently heard some news about a colleague from my residency. He's doing quite well for himself, holding a full-time job and also covering extra hours on the side. I know more than a few full-time radiologists whose annual salaries are less than half of what he's earning, so it was a...

TOPICS:

Luminex 1Q profit surges on revenue boost

May 9, 2011 12:45 pm | by The Associated Press | Comments

Luminex Corp., which makes testing systems for biotechnology companies, said Monday that its first-quarter profit more than doubled on a boost in system and product sales.The company said it earned $4.5 million, or 11 cents per share, compared with profit of $1.9 million, or 5 cents per share,...

Advertisement

Study finds teens often willing to accept free or low-cost rapid HIV testing

May 9, 2011 12:38 pm | by EurekAlert | Comments

(Lifespan) New findings from the Bradley Hasbro Children's Research Center suggest widespread, routine HIV testing may be a viable HIV prevention strategy for adolescents.

TOPICS:

Lpath, Inc. CEO Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

May 9, 2011 12:37 pm | by Bio-Medicine.Org | Comments

NEW YORK, May 9, 2011 /- Lpath, Inc. (OTC: LPTN), the category leader in bioactive-lipid-targeted therapeutics, today announced that their May 5th RetailInvestorConferences.com presentation is available for on-demand viewing. LINK: www.retailinvestorconferences.com > Click the red...

TOPICS:

Generex Biotechnology Corporation CEO Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com

May 9, 2011 12:35 pm | by Bio-Medicine.Org | Comments

NEW YORK, May 9, 2011 /- Generex Biotechnology Corporation ( www.generex.com ) (OTC:GNBT) announced that their May 5th RetailInvestorConferences.com presentation is available for on-demand viewing. LINK: www.retailinvestorconferences.com >Click the red "register/ watch event now"...

TOPICS:

Former NBA Star Allan Houston Joins "Apply Yourself!" Campaign to Raise Awareness of Osteoarthritis Hand and Knee Pain

May 9, 2011 11:33 am | by Bio-Medicine.Org | Comments

CHADDS FORD, Pa., May 9, 2011 /- Endo Pharmaceuticals, a leading healthcare solutions company, today announced the launch of the "Apply Yourself!" Campaign, created to encourage people suffering from osteoarthritis (OA) hand and knee pain to make pain relief a top personal priority....

TOPICS:

Steris 4Q profit rises 31 percent as sales pick up

May 9, 2011 10:46 am | by The Associated Press | Comments

Medical products maker Steris Corp. said Monday its profit rose 31 percent in its fiscal fourth quarter as revenue improved in all three of its businesses, particularly the health care division.Steris said its net income rose to $39 million, or 65 cents per share, in the three months ended...

Advertisement

Yale and Rush University scientists receive Sanberg Awards from ASNTR

May 9, 2011 10:36 am | by EurekAlert | Comments

(University of South Florida (USF Health)) At the 18th Annual Conference of the American Society of Neural Therapy and Repair, held in conjunction with the 11th International Conference on Neuronal Transplantation and Repair May 4-8, 2011, in Clearwater Beach, Fla., the ASNTR...

TOPICS:

Elsevier acquires Fisterra.com, a reference solution for Spanish primary care professionals

May 9, 2011 9:36 am | by EurekAlert | Comments

(Elsevier) Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of Fisterra.com, an award winning, widely used e-clinical reference solution in Spain. Fisterra was launched in 2002 by two...

TOPICS:

Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICIDâ„¢ Phase 3 Data

May 9, 2011 9:33 am | by Bio-Medicine.Org | Comments

CHICAGO, May 9, 2011 /- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR ) today announced the presentation of two abstracts at the 2011 Digestive Disease Week (DDW) conference highlighting additional analyses of data from Phase 3 trials of DIFICID™ (fidaxomicin), an investigational...

TOPICS:

AGA announces prestigious recognition award recipients

May 9, 2011 8:39 am | by EurekAlert | Comments

(American Gastroenterological Association) Each year, the American Gastroenterological Association honors several individuals for their outstanding contributions and achievements in gastroenterology through its prestigious recognition awards.

TOPICS:

MEMS Market Outlook: Yole Développement ups its forecast on current market strength

May 9, 2011 8:39 am | by I-Micronews | Comments

With the strong demand we?re currently seeing across a broad range of MEMS markets, Yole Développement now expects the sector to see 16% growth in 2011, to reach a $10.0 billion market this year.

Sanofi drops aventis name

May 9, 2011 8:38 am | by Mass High Tech: The Journal of New England Technology | Comments

French drug company Sanofi-aventis SA, the new parent company of Cambridge biotech Genzyme Corp., has simplified its name to Sanofi at its annual shareholders meeting on Friday.

Court approves Molecular Insight Ch. 11 reorganization plan

May 9, 2011 8:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Molecular Insight Pharmaceuticals Inc. is set to emerge from Chapter 11 bankruptcy protection as a restructured company, following the confirmation last week of its amended plan of reorganization by the U.S. Bankruptcy Court for the District of Massachusetts.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading